GMIN, to be honest this sounded very differently
Post# of 36536
(Total Views: 349)
Posted On: 08/11/2020 1:06:15 PM
GMIN,
to be honest this sounded very differently from Todd yesterday. It is indeed still their highest priority to get both GNBT and NGIO listed on a national exchange. When I asked him about the recent drop in pps, he did not want to comment on my suggestion of a correlation between the funding deal and the drop in pps, but he stated that share price manipulation in general is very common on the OTC and below, which is why they are trying everything they can to get uplisted.
One of those misconceptions i mentioned yesterday that Todd helped me resolve is that the S1s for GNBT and NGIO are actually fully independent, the opposite is actually true. The S1 for NGIO can only be approved by the SEC after that of GNBT is. And I actually see that Iliad 8k that docj posted a link to today as yet another request from the SEC being check marked.
So it is just one step at a time to get to the S1 approval and once that is approved, the NGIO S1 should follow very shortly thereafter. Only then the road is cleared for tapping into the Oasis funding for NGIO, which will remove the going concern, and then NGIO will be ready for its IPO.
So I am sure that besides NGIO's attempt to get a vaccine developed/peptide testing done, there is one other major focus for GNBT and that is to get both companies listed on a national exchange. Unfortunately, though this entire process seems to take forever or at least much longer than all of us AND THEM, were hoping it to.
to be honest this sounded very differently from Todd yesterday. It is indeed still their highest priority to get both GNBT and NGIO listed on a national exchange. When I asked him about the recent drop in pps, he did not want to comment on my suggestion of a correlation between the funding deal and the drop in pps, but he stated that share price manipulation in general is very common on the OTC and below, which is why they are trying everything they can to get uplisted.
One of those misconceptions i mentioned yesterday that Todd helped me resolve is that the S1s for GNBT and NGIO are actually fully independent, the opposite is actually true. The S1 for NGIO can only be approved by the SEC after that of GNBT is. And I actually see that Iliad 8k that docj posted a link to today as yet another request from the SEC being check marked.
So it is just one step at a time to get to the S1 approval and once that is approved, the NGIO S1 should follow very shortly thereafter. Only then the road is cleared for tapping into the Oasis funding for NGIO, which will remove the going concern, and then NGIO will be ready for its IPO.
So I am sure that besides NGIO's attempt to get a vaccine developed/peptide testing done, there is one other major focus for GNBT and that is to get both companies listed on a national exchange. Unfortunately, though this entire process seems to take forever or at least much longer than all of us AND THEM, were hoping it to.
(5)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼